|
Volumn 373, Issue 10, 2015, Pages 977-
|
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes [1]
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOSYLATED HEMOGLOBIN;
LIPID;
METFORMIN;
SULFONYLUREA;
ANTIDIABETIC AGENT;
GLUCOSE BLOOD LEVEL;
BLOOD PRESSURE;
BODY MASS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CLINICAL DECISION MAKING;
DRUG USE;
FOLLOW UP;
GLYCEMIC CONTROL;
HEART FAILURE;
HEART PROTECTION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LETTER;
LIFESTYLE;
LIPID BLOOD LEVEL;
METHODOLOGY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PATIENT DECISION MAKING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
VETERAN;
BLOOD;
CARDIOVASCULAR DISEASES;
FEMALE;
GLUCOSE BLOOD LEVEL;
MALE;
METABOLISM;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
|
EID: 84940861344
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1508386 Document Type: Letter |
Times cited : (1)
|
References (2)
|